| Bioactivity | BQ-3020 (TFA) is a selective agonist of ETB receptor, inhibits [125I]ET-1 binding to ETB receptor with an IC50 of 0.2 nM in cerebellum, and causes vasoconstriction[1]. | ||||||
| Name | BQ-3020 TFA | ||||||
| Sequence | N-Acetyl-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | ||||||
| Shortening | N-Acetyl-LMDKEAVYFAHLDIIW | ||||||
| Formula | C98H141F3N20O27S | ||||||
| Molar Mass | 2120.35 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
BQ-3020 TFA
CAS: F: C98H141F3N20O27S W: 2120.35
BQ-3020 (TFA) is a selective agonist of ETB receptor, inhibits ET-1 binding to ETB receptor with an IC50 of 0.2 nM in ce
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.